Stem cell therapy for muscular dystrophy

Bibliography

• O'BRIEN KF, KUNKEL LM: Dystrophin and muscular dystrophy: past, present, and future. Ma Genet. Metab. (2001) 74:75–88.
   PubMed Web of Science ®Google Scholar
• DURBEEJ M, CAMPBELL KP: Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Carr: Opin Genet. Dev. (2002) 12:349–361.
   PubMed Web of Science ®Google Scholar
• EHMSEN J, POON E, DAVIES K: The dystrophin-associated protein complex. J. Cell Sci. (2002) 115:2801–2803.
   PubMed Web of Science ®Google Scholar
• MONACO AP, NEVE RL,COLLETTI-FEENER C et al.: Isolation of candidate eDNAs for portions of the Duchenne muscular dystrophy gene. Nature (1986) 323:646–650.
   Google Scholar
• BURGHES AHM, LOGAN C, HU X et at.: A eDNA clone from the Duchenne/Becker muscular dystrophy gene. Nature (1987) 328:434–437.
   Google Scholar
• HOFFMAN EP, BROWN RH, KUNKEL LM: Dystrophin: the protein product of the Duchenne Muscular Dystrophy locus. Cell (1987) 51:919–928.
   PubMed Web of Science ®Google Scholar
• HOFFMAN EP, FISCHBECK KH, BROWN RH et al.: Dystrophin characterization in muscle biopsies from Duchenne and Becker muscular dystrophy patients. N Engl. J. Med. (1988) 318:1363–1368.
   PubMed Web of Science ®Google Scholar
• BULFIELD G, SILLER WG, WIGHT PAL, MOORE KJ:X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Nati Acad. Sci. USA (1984) 81:1189–1192.
   PubMed Web of Science ®Google Scholar
• SICINSKI P, GENG Y, RYDER-COOK AS et al: The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science (1989) 244:1578–1580.
   PubMed Web of Science ®Google Scholar
• HOFFMAN EP, MORGAN JE,WATKINS SC, PARTRIDGE TA: Somatic reversion/suppression of the mouse mdx phenotype in viva J. Neurol Sci. (1990) 99:9–25.
   Web of Science ®Google Scholar
• LU QL, MORRIS GE, WILTON SD et al: Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion. J. Cell Biol. (2000) 148:985–996.
   PubMed Web of Science ®Google Scholar
• DANKO I, CHAPMAN V, WOLFF JA: The frequency of revertants in mdx mouse genetic models for Duchenne muscular dystrophy. Pediatr. Res. (1992) 32:128–131.
   PubMed Web of Science ®Google Scholar
• ANDERSON DJ, GAGE FH, WEISSMAN IL: Can stem cells cross lineage boundaries? Nat. Med. (2001) 7:393–395.
   Web of Science ®Google Scholar
• BLAU HM, BRAZELTON TR,WEIMANN JM: The evolving concept of a stem cell: entity or function? Cell (2001) 105:829–841.
   PubMed Web of Science ®Google Scholar
• KRAUSE DS, THEISE ND, COLLECTOR MI et al: Multi-organ, multi-lineage engraftment by a single BM-derived stem cell. Cell (2001) 105:369–377.
   PubMed Web of Science ®Google Scholar
• •This work demonstrates that rare HSCs are pluripotent and capable of homing to the BM, and confer long-term repopulation of primary and secondary irradiated hosts.
   Google Scholar
• BJORNSON CR, RIETZE RL, REYNOLDS BA, MAGLI MC, VESCOVI AL: Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science (1999) 283:534–537.
   PubMed Web of Science ®Google Scholar
• CLARKE DL, JOHANSSON CB, WILBERTZ J et al.: Generalized potential of adult neural stem cells. Science (2000) 288:1660–1663.
   PubMed Web of Science ®Google Scholar
• RIETZE RL, VALCANIS H,BROOKER GF et al.: Purification of a pluripotent neural stem cell from the adult mouse brain. Nature (2001) 412:736–739.
   Google Scholar
• ALONSO L, FUCHS E: Stem cells of the skin epithelium. Proc. Natl. Acad. Sci. USA (2003) 100\(Suppl. 1):11830–11835.
   Google Scholar
• BELTRAMI AP, BARLUCCHI L, TORELLA D et al.: Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell (2003) 114:763–776.
   PubMed Web of Science ®Google Scholar
• GUSSONI E, SONEOKA Y, STRICKLAND C et al.: Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature (1999) 401:390–394.
   PubMed Web of Science ®Google Scholar
• •This work demonstrates that BM or muscle SP cells can be delivered systemically to reconstitute the BM of lethally-irradiated mdxmice, and participate in muscle repair.
   Google Scholar
• JACKSON KA, MIT, GOODELL MA: Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc. Natl. Acad. Sci. USA (1999) 96:14482–14486.
   PubMed Web of Science ®Google Scholar
• •This paper also describes the isolation of cells with hematopoietic potential from skeletal muscle.
   Google Scholar
• HESLOP L, MORGAN JE,PARTRIDGE TA: Evidence for a myogenic stem cell that is exhausted in dystrophic muscle.j Cell Sci. (2000) 113\(Pt 12):2299–2308.
   Google Scholar
• ASAKURA A, SEALEP,GIRGIS-GABARDO A, RUDNICKI MA: Myogenic specification of side population cells in skeletal muscle. J. Cell Biol. (2002) 159:123–134.
   PubMed Web of Science ®Google Scholar
• •This paper demonstrates that satellite cells and muscle-derived SP cells are distinct populations. Different subpopulations of muscle-derived SP cells have distinct potentials to differentiate into muscle and haematopoietic lineages.
   Google Scholar
• CAO B, ZHENG B, JANKOWSKI RJ et al.: Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potential. Nat. Cell Biol. (2003) 5(7)640–646.
   Google Scholar
• •The authors demonstrate that clones of MDSCs differentiate into multiple lineages, yet retain their myogenic potential afterhaematopoietic differentiation.
   Google Scholar
• WAKITANI S, SAITO T, CAPLAN Al: Myogenic cells derived from rat BM mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve (1995) 18:1417–1426.
   PubMed Web of Science ®Google Scholar
• JIANG Y, JAHAGIRDAR BN, REINHARDT RL et al.: Pluripotency ofmesenchymal stem cells derived from adult marrow. Nature (2002) 418:41–49.
   PubMed Web of Science ®Google Scholar
• BRAZELTON TR, ROSSI FM,KESHET GI, BLAU HM: From marrow to brain: expression of neuronal phenotypes in adult mice. Science (2000) 290:1775–1779.
   PubMed Web of Science ®Google Scholar
• MEZEY E, CHANDROSS KJ, HARTA G, MAKI RA, MCKERCHER SR: Turning blood into brain: cells bearing neuronal antigens generated in vivo from BM. Science (2000) 290:1779–1782.
   PubMed Web of Science ®Google Scholar
• LAGASSE E, CONNORS H, AL-DHALIMY M et al.: Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. (2000) 6:1229–1234.
   PubMed Web of Science ®Google Scholar
• FERRARI G, CUSELLA-DE ANGELIS G, COLETTA M et al.: Muscle regeneration by BM-derived myogenic progenitors. Science (1998) 279:1528–1530.
   PubMed Web of Science ®Google Scholar
• ••This landmark paper documents theability of transplanted BM cells to migrate to sites of muscle injury and differentiate into muscle.
   Google Scholar
• BITTNER RE, SCHOFER C, WEIPOLTSHAMMER K et al: Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat. Embryo]. (Berl) (1999) 199:391–396.
   PubMedGoogle Scholar
• GOODELL MA, BROSE K, PARADIS G, CONNER AS, MULLIGAN RC: Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. I Exp. Med. (1996) 183:1797–1806.
   PubMed Web of Science ®Google Scholar
• •This paper describes the initial technique of isolating SP cells via FACS andHoechst dye.
   Google Scholar
• GOODELL MA, ROSENZWEIG M, KIM H et al.: Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat. Med. (1997) 3:1337–1345.
   PubMed Web of Science ®Google Scholar
• FERRARI G, STORNAIUOLO A, MAVILIO F: Failure to correct murine muscular dystrophy. Nature (2001) 411:1014–1015.
   PubMed Web of Science ®Google Scholar
• BRAZELTON TR, NYSTROM M, BLAU HM: Significant differences among skeletal muscles in the incorporation of BM-derived cells. Dev. Biol. (2003) 262:64–74.
   PubMed Web of Science ®Google Scholar
• GUSSONI E, BENNETT RR, MUSKIEWICZ KR et al: Long-term persistence of donor nuclei in a Duchennemuscular dystrophy patient receiving BMtransplantation. J. Clin. Invest. (2002) 110:807–814.
   PubMed Web of Science ®Google Scholar
• •This paper describes the ability of exogenous human BM cells to fuse into human recipient skeletal muscle and persist for at least 13 years.
   Google Scholar
• TERADA N, HAMAZAKI T, OKA M et al.: BM cells adopt the phenotype of other cells by spontaneous cell fusion. Nature (2002) 416:542–545.
   PubMed Web of Science ®Google Scholar
• YING QL, NICHOLS J, EVANS EP, SMITH AG: Changing potency by spontaneous fusion. Nature (2002) 416:545–548.
   PubMed Web of Science ®Google Scholar
• CASTRO RE JACKSON KA,GOODELL MA et al.: Failure of BM cells to transdifferentiate into neural cells in vivo. Science (2002) 297:1299.
   Google Scholar
• WAGERS AJ, SHERWOOD RI, CHRISTENSEN JL, WEISSMAN IL: Little evidence for developmental plasticity of adult hematopoietic stem cells. Science (2002) 5:5.
   Google Scholar
• •This paper reports that HSCs are unable to transdifferentiate into non-haematopoietic tissues in the absence of tissue injury.
   Google Scholar
• WEIMANN JM, CHARLTON CA, BRAZELTON TR, HACKMAN RC, BLAU HM: Contribution of transplanted BM cells to Purkinje neurons in human adult brains. Proc. Nati Acad. Sci. USA (2003) 100:2088–2093.
   PubMed Web of Science ®Google Scholar
• •This study demonstrates that BM cells can contribute to the generation of Purkinje neurons by fusion.
   Google Scholar
• BISCHOFF R: The satellite cell and muscle regeneration. In: Myology, 2'd Edition, Engel AG, Franzini-Armstrong C (Eds), McGraw Hill (1994):97–119. Vol 1.
   Google Scholar
• SEALE P, RUDNICKI MA: A new look at the origin, function, and `stem-cell' status of muscle satellite cells. Dev. Biol. (2000) 218:115–124.
   PubMed Web of Science ®Google Scholar
• CORNELISON DD, WOLD BJ: Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev. Biol. (1997) 191:270–283.
   PubMed Web of Science ®Google Scholar
• BEAUCHAMP JR, MORGAN JE, PAGEL CN, PARTRIDGE TA: Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. j. Cell Biol. (1999) 144:1113–1122.
   PubMed Web of Science ®Google Scholar
• BEAUCHAMP JR, HESLOP L, YU DS et al.: Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. Cell Biol. (2000) 151:1221–1234.
   PubMed Web of Science ®Google Scholar
• ODELBERG SJ, KOLLHOFF A, KEATING MT: Dedifferentiation of mammalian myotubes induced by msxl. Cell (2000) 103:1099–1109.
   PubMed Web of Science ®Google Scholar
• SEALE P, SABOURIN LA, GIRGIS-GABARDO A et al.: Pax7 is required for the specification of myogenic satellite cells. Cell (2000) 102:777–786.
   PubMed Web of Science ®Google Scholar
• ••This work demonstrates that Pax7 isrequired for the development of satellite cells, but not embryonic or fetal muscle cell lineages.
   Google Scholar
• GROUNDS MD, MCGEACHIE JK: A model of myogenesis M vivo, derived from detailed autoradiographic studies of regenerating skeletal muscle, challenges the concept of quantal mitosis. Cell Tissue Res. (1987) 250:563–569.
   PubMed Web of Science ®Google Scholar
• RANTANEN J, HURME T, LUKKA R, HEINO J, KALIMO H: Satellite cell proliferation and the expression of myogenin and desmin in regenerating skeletal muscle: evidence for two different populations of satellite cells. Lab. Invest. (1995) 72:341–347.
   PubMed Web of Science ®Google Scholar
• SCHULTZ E: Satellite cell proliferative compartments in growing skeletal muscles. Dev. Biol. (1996) 175:84–94.
   PubMed Web of Science ®Google Scholar
• DE ANGELIS L, BERGHELLA L, COLETTA M et al.: Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration. Cell Biol. (1999) 147:869–878.
   PubMed Web of Science ®Google Scholar
• •This paper demonstrates that clonable skeletal myogenic cells are present in the embryonic dorsal aorta of mouse embryos, and that these cells are capable of participating in postnatal muscle growth and regeneration upon transplantation.
   Google Scholar
• WADA MR, INAGAWA-OGASHIWA M, SHIMIZU S, YASUMOTO S, HASHIMOTO N: Generation of different fates from multipotent muscle stem cells. Development (2002) 129:2987–2995.
   PubMed Web of Science ®Google Scholar
• KARPATI G, POUILOT Y, ZUBRZYCKA-GAARN E et al.: Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. Am. Pathol (1989) 135:27–32.
   PubMed Web of Science ®Google Scholar
• •This paper demonstrates that use of wild-type myoblasts transplanted via intramuscular injection into mdrmice canfuse into dystrophic muscle and lead to production of dystrophin.
   Google Scholar
• PARTRIDGE TA, MORGAN JE, COULTON GR, HOFFMAN EP, KUNKEL LM: Conversion of mdx myofibers from dystrophin negative to positive by injection of normal myoblasts. Nature (1989) 337:176–179.
   PubMed Web of Science ®Google Scholar
• ••This landmark paper demonstrates thatnormal myoblasts injected into the muscles of mdxmice can fuse with pre-existing mdxmuscle fibres and render them dystrophin-positive.
   Google Scholar
• GUSSONI E, PAVLATH GK,LANCTOT AM et al.: Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature (1992) 356:435–438.
   Google Scholar
• HUARD J, BOUCHARD J-P, ROY R et al.: Human myoblast transplantation: preliminary results of 4 cases. Muscle Nerve (1992) 15:550–560.
   PubMed Web of Science ®Google Scholar
• KARPATI G, AJDUKOVIC D,ARNOLD D et al.: Myoblast transfer in Duchenne muscular dystrophy. Ann. Neurol (1993) 34:8–17.
   Google Scholar
• MENDELL JR, KISSEL JT, AMATO AAet al.: Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N Engl. Med. (1995) 333:832–838.
   Google Scholar
• MORANDI L, BERNASCONI P, GEBBIA M et al.: Lack of mRNA and dystrophin expression in DMD patients three months after myoblast transfer. Neuromuscul Disord. (1995) 5:291–295.
   PubMed Web of Science ®Google Scholar
• NEUMEYER AM, CROS D,MCKENNA-YASEK D et al.: Pilot study of myoblast transfer in the treatment of Becker muscular dystrophy. Neurology (1998) 51:589–592.
   Google Scholar
• ROY R, TREMBLAY JP, HUARD J et al.: Antibody formation after myoblast transplantation in Duchenne-dystrophic patients, donor HLA compatible. Transpl. Proc. (1993) 25:995–997.
   PubMed Web of Science ®Google Scholar
• GUSSONI E, BLAU HM, KUNKEL LM: The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat. Med. (1997) 3:970–977.
   PubMed Web of Science ®Google Scholar
• QU Z, BALKIR L, VAN DEUTEKOM JC et al.: Development of approaches to improve cell survival in myoblast transfer therapy.j Cell Biol. (1998) 142:1257–1267.
   Google Scholar
• LEE JY, QU-PETERSEN Z, CAO B et al: Clonal isolation of muscle-derived cells capable of enhancing muscle regenerationand bone healing. " Cell Biol. (2000) 150:1085–1100.
   PubMed Web of Science ®Google Scholar
• QU-PETERSEN Z, DEASY B,JANKOWSKI R et al.: Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. Cell Biol. (2002) 157:851–864.
   Google Scholar
• •This describes the isolation of MDSCs which are capable of proliferation and differentiation into muscle, neural and endothelial lineages in vitro and in vivo.
   Google Scholar
• TORRENTE Y, TREMBLAY JP, PISATI F et al.: Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. .1. Cell Biol. (2001) 152:335–348.
   Google Scholar
• ZHOU S, SCHUETZ JD, BUNTING KDet al.: The ABC transporter Bcrpl/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. (2001) 7:1028–1034.
   Google Scholar
• ZHOU S, MORRIS JJ, BARNES Y et al.: Bcrpl gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cellsM vivo. Proc. Natl. Acad. Sci. USA (2002) 6:6.
   Google Scholar
• MCKINNEY-FREEMAN SL,JACKSON KA, CAMARGO FD et al.: Muscle-derived hematopoietic stem cells are hematopoietic in origin. Proc. Natl. Acad. Sci. USA (2002) 99:1341–1346.
   Google Scholar
• MCKINNEY-FREEMAN SL,MAJKA SM, JACKSON KA et al.: Altered phenotype and reduced function of muscle-derived hematopoietic stem cells. Exp. Hematol (2003) 31:806–814.
   Google Scholar
• MINASI MG, RIMINUCCI M, DE ANGELIS L et al.: The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development (2002) 129:2773–2783.
   Google Scholar
• SAMPAOLESI M, TORRENTE Y, INNOCENZI A et al.: Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science (2003) 301:487–492.
   PubMed Web of Science ®Google Scholar
• ••This paper reports the first intra-arterialdelivery of wild-type mesangioblasts to correct the dystrophic phenotype of a-sarcoglycan null mice. The incorporation rate is up to 50% - the most successful thus far.
   Google Scholar
• LABARGE MA, BLAU HM: Biological progression from adult BM to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell (2002) 111:589–601.
   PubMed Web of Science ®Google Scholar
• ••This work shows that transplanted BMcells can participate in the regeneration of injured muscle in mice by first giving rise to the muscle satellite cell. The authors propose that BM cells can differentiate into non-haematopoietic tissues via a tissue-specific stem cell or precursor (such as the muscle satellite cell).
   Google Scholar
• PARKER MH, SEALE P, RUDNICKI MA: Looking back to the embryo: defining transcriptional networks in adult myogenesis. Nat. Rev Genet. (2003) 4:497–507.
   PubMed Web of Science ®Google Scholar
• TORRENTE Y, CAMIRAND G, PISATI F et al.: Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model." Cell Biol. (2003) 162:511–520.
   Google Scholar
• DWORAK HA, SINK H: Myoblast fusion in Drosophila. Bioessays (2002) 24:591–601.
   PubMed Web of Science ®Google Scholar
• CHEN EH, PRYCE BA, TZENG JA, GONZALEZ GA, OLSON EN: Control of myoblast fusion by a guanine nucleotide exchange factor, loner, and its effector ARF6. Cell (2003) 114:751–762.
   PubMed Web of Science ®Google Scholar
• HORSLEY V, JANSEN KM, MILLS ST, PAVLATH GK: IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell (2003) 113:483–494.
   PubMed Web of Science ®Google Scholar
• ••This paper demonstrates a novel role forIL-4 in the regulation of the fusion of myoblasts with myotubes and suggests a potential therapeutic role of IL-4 in muscle disorders.
   Google Scholar
• TINSLEY JM, POTTER AC, PHELPS SR et al.: Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene [see comments]. Nature (1996) 384:349–353.
   PubMed Web of Science ®Google Scholar
• RAFAEL IA, TINSLEY JM, POTTER AC, DECONINCK AE, DAVIES KE: Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice. Nat. Genet. (1998) 19:79–82.
   PubMed Web of Science ®Google Scholar
• •In this paper, the authors demonstrate that expression of a truncated utrophintransgene within the skeletal muscle of mice null for both dystrophin and utrophin rescues the clinical and pathological phenotype. This pharmacological approach alleviates the dystrophic pathology by compensating for the lack of dystrophin through utrophin.
   Google Scholar
• BARTON ER, MORRIS L, MUSARO A, ROSENTHAL N, SWEENEY HL: Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice." Cell Biol. (2002) 157:137–148.
   PubMed Web of Science ®Google Scholar
• MCCROSKERY S, THOMAS M, MAXWELL L, SHARMA M, KAMBADUR R: Myostatin negatively regulates satellite cell activation and self-renewal. ". Cell Biol. (2003) 162:1135–1147.
   PubMed Web of Science ®Google Scholar
• BOGDANOVICH S, KRAG TO, BARTON ER et al.: Functional improvement of dystrophic muscle by myostatin blockade. Nature (2002) 420:418–421.
   PubMed Web of Science ®Google Scholar
• •Here, the authors demonstrate that intraperitoneal injections of blocking antibodies against myostatin in mix-mice lead to increased muscle mass and decreased muscle degeneration. The functional improvement of dystrophic muscle via myostatin blockade is one novel pharmacological approach to the treatment of DMD.
   Google Scholar
• GILBERT R, NALBANOGLU J, TINSLEY JM et al.: Efficient utrophin expression following adenovirus gene transfer in dystrophic muscle.Biochem. Biophys. Res. Commun. (1998) 242:244–247.
   PubMed Web of Science ®Google Scholar
• HOWELL JM, LOCHMULLER H, O'HARA A et al.: High-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: prolongation of expression with immunosuppression. Hum. Gene The]: (1998) 9:629–634.
   Google Scholar
• WAKEFIELD PM, TINSLEY JM, WOOD IVII et al: Prevention of the dystrophic phenotype in dystrophin/ utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene. Gene Ther. (2000) 7:201–204.
   PubMed Web of Science ®Google Scholar
• WANG B, LI J, XIAO X: Adeno-associatedvirus vector carrying humanminidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model. Proc. Natl. Acad. Sci. USA (2000) 97:13714–13719.
   PubMed Web of Science ®Google Scholar
• •This paper describes the use of minimal functional dystrophin units which can be delivered via adeno-associated viral vectors. Delivery of minidystrophin via adeno-associated virus to mdxmice ameliorated the dystrophic pathology.
   Google Scholar
• HARPER SQ, HAUSER MA, DELLORUSSO C et al.: Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat. Med. (2002) 8:253–261.
   PubMed Web of Science ®Google Scholar
• •This paper also demonstrates the promising potential of gene therapy using adeno-associated viruses to deliver micro-dystrophins to ameliorate the pathology present in mdx mice.
   Google Scholar
• DE ANGELIS FG, STHANDIER O, BERARDUCCI B et al.: Chimeric snRNA molecules carrying antisense sequences against the splice junctions of exon 51 of the dystrophin pre-mRNA induce exon skipping and restoration of a dystrophin synthesis in Delta 48-50 DMD cells. Proc. Natl. Acad. Sci. USA (2002) 99:9456–9461.
   PubMed Web of Science ®Google Scholar
• RANDO TA: Oligonucleotide-mediated gene therapy for muscular dystrophies. Neuromuscul Disord. (2002) 12\(Suppl. 1):555–560.
   Google Scholar
• •This paper reviews the novel approach of using oligonucleotides to repair frameshift mutations in the dystrophin gene.
   Google Scholar